Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Division of Hematology, Department of Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Leuk Lymphoma. 2021 May;62(5):1116-1122. doi: 10.1080/10428194.2020.1855347. Epub 2020 Dec 7.
We reviewed 341 consecutive cases of marginal zone lymphoma (MZL) (47) or follicular lymphoma (FL) (294) of which 7 were difficult to distinguish due to perceived coexpression of BCL6 and BCL2 by tumor cells in follicular foci. This stimulated us to develop dual BCL6/BCL2 immunohistochemistry, allowing us to assess coexpression among individual cells. Dual staining confirmed coexpression in 6 of 7 cases, all extranodal MZL (ENMZL) based on overall features and representing 13% of MZL in this series. These findings confirm that MZL cells have plasticity regarding protein expression within the germinal center (GC) microenvironment, an important diagnostic pitfall. Intriguingly, in all MZL expressing BCL6, non-neoplastic GC B cells within colonized follicles showed diminished or absent CD10 expression but preserved BCL6 and high ki67. This finding suggests plasticity of CD10 expression in non-neoplastic GC B cells in the context of colonization by MZL, possibly related to NF-kB dysregulation.
我们回顾了 341 例连续的边缘区淋巴瘤(MZL)(47 例)或滤泡性淋巴瘤(FL)(294 例)病例,其中 7 例由于肿瘤细胞在滤泡灶中表现出 BCL6 和 BCL2 的共表达,难以区分。这促使我们开发了双重 BCL6/BCL2 免疫组化,使我们能够评估单个细胞之间的共表达。双重染色在 7 例中的 6 例中均证实了共表达,所有这些均为基于整体特征的结外 MZL(ENMZL),占该系列中 MZL 的 13%。这些发现证实了 MZL 细胞在生发中心(GC)微环境中的蛋白表达具有可塑性,这是一个重要的诊断陷阱。有趣的是,在所有表达 BCL6 的 MZL 中,定植滤泡内的非肿瘤性 GC B 细胞显示 CD10 表达减少或缺失,但保留了 BCL6 和高 ki67。这一发现表明,在 MZL 定植的情况下,非肿瘤性 GC B 细胞中 CD10 表达具有可塑性,可能与 NF-κB 失调有关。